Cardlytics Stock Buy Hold or Sell Recommendation
| CDLX Stock | USD 2.47 0.40 19.32% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Cardlytics is 'Strong Sell'. A buy or sell recommendation is an automated directive regarding whether to purchase or sell Cardlytics given historical horizon and risk tolerance. When we issue a 'buy' or 'sell' recommendation for Cardlytics, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out Cardlytics Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For more information on how to buy Cardlytics Stock please use our How to Invest in Cardlytics guide. In addition, we conduct extensive research on individual companies such as Cardlytics and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Cardlytics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
Cardlytics |
Execute Cardlytics Buy or Sell Advice
The Cardlytics recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Cardlytics. Macroaxis does not own or have any residual interests in Cardlytics or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Cardlytics' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Very risky | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Quite High | Details | |
Economic Sensitivity | Actively responds to the market | Details | |
Investor Sentiment | Impartial | Details | |
Analyst Consensus | Hold | Details | |
Financial Strenth (F Score) | Poor | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Possible Manipulator | Details |
Cardlytics Trading Alerts and Improvement Suggestions
| Cardlytics generated a negative expected return over the last 90 days | |
| Cardlytics has high historical volatility and very poor performance | |
| Cardlytics has high likelihood to experience some financial distress in the next 2 years | |
| Cardlytics currently holds 221.65 M in liabilities with Debt to Equity (D/E) ratio of 0.42, which is about average as compared to similar companies. Cardlytics has a current ratio of 0.88, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Cardlytics' use of debt, we should always consider it together with its cash and equity. | |
| The entity reported the previous year's revenue of 278.3 M. Net Loss for the year was (189.3 M) with profit before overhead, payroll, taxes, and interest of 120.89 M. | |
| Cardlytics currently holds about 157.04 M in cash with (8.82 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.77, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Cardlytics has a poor financial position based on the latest SEC disclosures | |
| Roughly 58.0% of Cardlytics shares are held by institutions such as insurance companies | |
| Latest headline from globenewswire.com: CDLX INVESTORS Contact Robbins LLP for Information About the Lead Plaintiff Deadline in the Class Action Against Cardlytics, Inc. |
Cardlytics Returns Distribution Density
The distribution of Cardlytics' historical returns is an attempt to chart the uncertainty of Cardlytics' future price movements. The chart of the probability distribution of Cardlytics daily returns describes the distribution of returns around its average expected value. We use Cardlytics price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Cardlytics returns is essential to provide solid investment advice for Cardlytics.
| Mean Return | -0.55 | Value At Risk | -9.12 | Potential Upside | 7.75 | Standard Deviation | 5.73 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Cardlytics historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Cardlytics Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument, such as Cardlytics, soars without any apparent reason? This usually happens because many institutional investors are aggressively trading Cardlytics back and forth among themselves.
| Shares | Dimensional Fund Advisors, Inc. | 2024-12-31 | 498.1 K | Citigroup Inc | 2024-12-31 | 477.3 K | Ubs O'connor Llc | 2024-12-31 | 450 K | Renaissance Technologies Corp | 2024-12-31 | 403.4 K | Charles Schwab Investment Management Inc | 2024-12-31 | 402.6 K | Morgan Stanley - Brokerage Accounts | 2024-12-31 | 389.8 K | Northern Trust Corp | 2024-12-31 | 373.8 K | Landscape Capital Management,llc | 2024-12-31 | 339.2 K | Pb Investment Partners, L.p. | 2024-12-31 | 338.2 K | Blackrock Inc | 2024-12-31 | 3.2 M | Vanguard Group Inc | 2024-12-31 | 2.7 M |
Cardlytics Cash Flow Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Change In Cash | 188.8M | (59.8M) | (111.6M) | (30.2M) | (26.2M) | (24.9M) | |
| Net Borrowings | (46.8M) | 196.2M | (200K) | (209K) | (240.4K) | (228.3K) | |
| Free Cash Flow | (17.7M) | (51.1M) | (67.4M) | (12.6M) | (8.8M) | (9.3M) | |
| Depreciation | 11.6M | 35.7M | 43.7M | 29.5M | 27.9M | 18.2M | |
| Other Non Cash Items | 6.4M | 18.7M | 335.7M | 77.5M | 112.2M | 66.7M | |
| Capital Expenditures | 11.0M | 10.1M | 12.6M | 13.5M | 12.4M | 0.0 | |
| Net Income | (55.4M) | (128.6M) | (465.3M) | (134.7M) | (189.3M) | (179.8M) | |
| End Period Cash Flow | 293.3M | 233.6M | 122.0M | 91.8M | 65.6M | 114.7M | |
| Change To Netincome | 16.5M | 32.6M | 46.8M | 377.3M | 433.9M | 455.6M | |
| Investments | (10.1M) | (506.7M) | (15.8M) | (10.1M) | (9.1M) | (9.5M) | |
| Change Receivables | (26.0M) | (2.4M) | (27.9M) | (4.5M) | (5.2M) | (5.5M) |
Cardlytics Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Cardlytics or Media sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Cardlytics' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Cardlytics stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.35 | |
β | Beta against Dow Jones | 1.95 | |
σ | Overall volatility | 5.77 | |
Ir | Information ratio | -0.08 |
Cardlytics Volatility Alert
Cardlytics exhibits very low volatility with skewness of 0.5 and kurtosis of 1.15. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Cardlytics' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Cardlytics' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Cardlytics Fundamentals Vs Peers
Comparing Cardlytics' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Cardlytics' direct or indirect competition across all of the common fundamentals between Cardlytics and the related equities. This way, we can detect undervalued stocks with similar characteristics as Cardlytics or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Cardlytics' fundamental indicators could also be used in its relative valuation, which is a method of valuing Cardlytics by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Cardlytics to competition |
| Fundamentals | Cardlytics | Peer Average |
| Return On Equity | -1.85 | -0.31 |
| Return On Asset | -0.0821 | -0.14 |
| Profit Margin | (0.68) % | (1.27) % |
| Operating Margin | (0.11) % | (5.51) % |
| Current Valuation | 262.75 M | 16.62 B |
| Shares Outstanding | 52.09 M | 571.82 M |
| Shares Owned By Insiders | 5.12 % | 10.09 % |
| Shares Owned By Institutions | 57.67 % | 39.21 % |
| Number Of Shares Shorted | 8.33 M | 4.71 M |
| Price To Earning | (3.47) X | 28.72 X |
| Price To Book | 1.55 X | 9.51 X |
| Price To Sales | 0.46 X | 11.42 X |
| Revenue | 278.3 M | 9.43 B |
| Gross Profit | 120.89 M | 27.38 B |
| EBITDA | 25.69 M | 3.9 B |
| Net Income | (189.3 M) | 570.98 M |
| Cash And Equivalents | 157.04 M | 2.7 B |
| Cash Per Share | 4.77 X | 5.01 X |
| Total Debt | 221.65 M | 5.32 B |
| Debt To Equity | 0.42 % | 48.70 % |
| Current Ratio | 0.90 X | 2.16 X |
| Book Value Per Share | 1.37 X | 1.93 K |
| Cash Flow From Operations | (8.82 M) | 971.22 M |
| Short Ratio | 10.59 X | 4.00 X |
| Earnings Per Share | (6.40) X | 3.12 X |
| Price To Earnings To Growth | (0.24) X | 4.89 X |
| Target Price | 3.3 | |
| Number Of Employees | 454 | 18.84 K |
| Beta | 1.63 | -0.15 |
| Market Capitalization | 128.65 M | 19.03 B |
| Total Asset | 392.71 M | 29.47 B |
| Retained Earnings | (1.3 B) | 9.33 B |
| Working Capital | 52.78 M | 1.48 B |
Note: Insider Trading [view details]
Cardlytics Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Cardlytics . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Cardlytics Buy or Sell Advice
When is the right time to buy or sell Cardlytics? Buying financial instruments such as Cardlytics Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Cardlytics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Impulse Thematic Idea Now
Impulse
Large corporations operating in retail, broadcasting, energy, airlines and telecom sectors. The Impulse theme has 39 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Impulse Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Cardlytics Stock Analysis
When running Cardlytics' price analysis, check to measure Cardlytics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cardlytics is operating at the current time. Most of Cardlytics' value examination focuses on studying past and present price action to predict the probability of Cardlytics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cardlytics' price. Additionally, you may evaluate how the addition of Cardlytics to your portfolios can decrease your overall portfolio volatility.